Health Care · Services-Offices & Clinics of Doctors of Medicine

AIRS Airsculpt Technologies, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 187094060 filings
Russell 2000

AIRS at a glance

Airsculpt Technologies, Inc. (AIRS, SEC CIK 1870940) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 6, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Airsculpt Technologies, Inc. (AIRS) reported revenue of $151.8 million (down 15.8% from FY2024) and a net loss of $11.7 million. Diluted EPS was -$0.19.
  • As of September 30, 2026, 21 institutional investment managers tracked by SignalX reported holding Airsculpt Technologies, Inc. (AIRS) shares worth $7.3 million in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Jashnani Yogesh on November 11, 2026 of 31,000 shares at $0.78 per share.
  • In the last 90 days, AIRS insiders reported 1 open-market purchase ($24K) and 0 open-market sales ($0) on Form 4, a net purchase of $24K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$151.8M
−15.8% vs prior year
Insiders · 90 days
1 buy · 0 sells
Net +$24K
13F holders
21 funds
$7.3M · +3 vs prior quarter
Latest 8-K
Nov 6, 2026
Item 1.01 · Item 1.02 · Item 2.02 · Item 2.03

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • Blue Torch covenant compliance: Leverage Ratio and Fixed Charge Coverage Ratio testing begins December 31, 2026
  • Blue Torch financing: floating interest rate up to Term SOFR plus 7.75%, above the 8.15% Credit Agreement rate
  • SEC baby-shelf rules: public float below $75.0 million could limit Form S-3 offerings to one-third of public float
  • Generative AI search: lower website traffic and consultation requests could increase patient acquisition costs
  • Blue Torch default risk: lenders could accelerate loans secured by substantially all assets

Management Discussion & Analysis

  • Q3 revenue $31.944M, down 8.7% YoY from $34.993M, driven by lower same-center cases
  • Operating margin (13.0%) vs (27.9%) YoY, while net margin (22.5%) vs (27.2%)
  • Same-center cases declined 9.6%; revenue per case rose 2.3% to $12,865
  • Cash $15.2M at September 30, up from $5.4M YoY; Q3 ATM proceeds $7.19M
  • Near-term headwinds: weaker cases and revenue; Blue Torch refinancing at Term SOFR plus 7.75% until November 5, 2031

AI summary of the AIRS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 6, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • $39.0M senior secured term loan refinanced existing debt, with $5.0M revolving capacity for working capital
  • Facilities mature November 5, 2031, secured by substantially all borrower and guarantor assets

Item 1.02: Termination of a Material Definitive Agreement

  • Existing Credit Agreement scheduled to mature November 15, 2027, terminated after full repayment
  • Term Loan proceeds refinanced all outstanding obligations under the prior facility

Item 2.02: Results of Operations and Financial Condition

  • Third-quarter and nine-month fiscal 2026 results announced for periods ended September 30, 2026
  • Exhibit 99.1 contains the detailed financial results and management commentary

Item 2.03: Creation of a Direct Financial Obligation

  • Item 2.03 links to Item 1.01, indicating a financing-related obligation was created or amended
  • Investor-relevant terms require review of Item 1.01, including borrowing amount, maturity, interest rate and covenants

Item EX-99.1: Item EX-99.1

  • Q3 revenue $31.9M, down 8.7%, with same-center cases down 9.6% to 2,483
  • Adjusted EBITDA $0.4M, margin 1.2% versus 8.7%, signaling sharp operating deleverage
Filed Nov 6, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Press release announces AirSculpt results for the three and nine months ended September 30, 2026
  • Exhibit 99.1 contains the financial results and non-GAAP-to-GAAP reconciliations

Item EX-99.1: Item EX-99.1

  • Q3 revenue $31.9M, down 8.7%, with same-center cases down 9.6%, signaling weaker demand despite revenue per case rising 2.3%
  • Adjusted EBITDA $0.4M, down from $3.0M, margin compressed to 1.2% from 8.7%, indicating significant operating deleverage
Filed Aug 12, 2026Full analysis →

Item 8.01: Other Events

  • Corporate headquarters relocating from Miami Beach, Florida to Tampa, Florida
  • Board-approved change effective for future SEC filings

AI summaries of AIRS 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for AIRS

Don't miss the next AIRS filing

  • Alerts as it files. A push when AIRS files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut AIRS, by share count.
  • Ask anything. An AI agent that reads every AIRS filing and answers with sources.

AIRS alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Jashnani YogeshBuyNov 11, 2026$0.78
Feinstein Adam TJMay 20, 2026-
Chu CarolineAMay 12, 2026-
Aaron Thomas JAMay 12, 2026-
Aaron Thomas JAMay 12, 2026-
Higgins KennethAMay 12, 2026-
Chernett JoreyBuyApr 17, 2026$2.54
Chernett JoreyEApr 17, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$180.3M$151.8M
Operating Income--$1.8M-$11.6M
Net Income-$4.5M-$8.3M-$11.7M
Op. Margin--1.0%-7.6%
Net Margin--4.6%-7.7%
Balance Sheet
Total Assets$204.0M$210.0M$187.3M
Equity-$79.3M$87.7M
ROE--10.4%-13.3%
Per Share
EPS$-0.08$-0.14$-0.19
Cash Flow
Operating CF$24.0M$11.3M$3.1M
CapEx-$14.0M$2.4M

Source: XBRL data in Airsculpt Technologies, Inc. (AIRS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate AIRS share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
AIRS shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202621$7.3M
Q2 202618$16.6M
Q1 202619$7.5M
Q4 202522$9.5M
Q3 202520$24.5M
Q2 202521$15.2M
Q1 202514$2.9M
Q4 20249$5.2M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 144 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

AIRS filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 12, 2026--
10-QNov 6, 2026Analysis
8-KNov 6, 2026Analysis-
8-KNov 6, 2026Analysis-
8-KAug 12, 2026Analysis-
8-KAug 10, 2026Analysis-
10-QAug 10, 2026Analysis
SC 13GJun 1, 2026-
4May 20, 2026-
4May 14, 2026-
8-KMay 14, 2026Analysis
4May 14, 2026-
4May 14, 2026-
8-KMay 8, 2026Analysis
10-QMay 8, 2026Analysis
4Apr 20, 2026--
4Apr 15, 2026--
4Apr 10, 2026--
4Apr 10, 2026--
4Apr 10, 2026--
4Apr 8, 2026--
8-KApr 6, 2026Analysis-
4Apr 6, 2026--
8-KApr 2, 2026Analysis-
10-KMar 31, 2026-

Related Health Care companies

All Health Care →

AIRS SEC filings: frequently asked questions

Are AIRS insiders buying or selling?

In the last 90 days, Airsculpt Technologies, Inc. (AIRS) officers, directors and 10% owners reported 1 open-market purchase worth $24,047 by 1 insider and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold AIRS stock?

As of September 30, 2026, the largest Airsculpt Technologies, Inc. (AIRS) holders among the 13F filers tracked by SignalX were BlackRock ($1.9 million), Citadel Advisors LLC ($1.0 million), Renaissance Technologies LLC ($790,000), Morgan Stanley ($733,000), Citizens Financial Group ($524,000). 13F-HR reports are filed up to 45 days after each quarter ends.

What was AIRS's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Airsculpt Technologies, Inc. (AIRS) reported revenue of $151.8 million (down 15.8% from FY2024) and a net loss of $11.7 million. Diluted EPS was -$0.19. The figures come from the XBRL data in the 10-K.

What did AIRS report in its latest 8-K?

Airsculpt Technologies, Inc. (AIRS) filed an 8-K on November 6, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition) and Item 2.03 (Creation of a Direct Financial Obligation). $39.0M senior secured term loan refinanced existing debt, with $5.0M revolving capacity for working capital.

What are the latest AIRS SEC filings?

Airsculpt Technologies, Inc. (AIRS) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 6, 2026 and a Form 4 insider filing on November 12, 2026.

What is AIRS's SEC CIK number?

Airsculpt Technologies, Inc. (AIRS)'s SEC Central Index Key (CIK) is 1870940. EDGAR lists every AIRS filing under that number.

Ask anything about AIRS

The research agent reads AIRS's filings, financials, insider trades and 13F holders, then answers with sources.